发明名称 PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS
摘要 <p>The present invention d ribs novel compounds of the formula:useful for the diagnosis and treatment of cancer, methods of imaging tumors in a patient, and methods of treating cancer in a patient. The present invention also provides novel compounds useful for monitoring therapeutic angiogenesis treatment and destruction of new angiogenic vasculature. The pharmaceuticals are comprised of a targeting moiety that binds to a receptor that is upregulated during angiogenesis, an optional linking group, and a therapeutically effective radioisotope or diagnostically effective imageable moiety. The imageable moiety is a gamma ray or positron emitting radioisotope, a magnetic resonance imaging contrast agent, an X-ray contrast agent, or an ultrasound contrast agent.</p>
申请公布号 SK13952000(A3) 申请公布日期 2001.12.03
申请号 SK20000001395 申请日期 1999.03.29
申请人 DUPONT PHARMACEUTICALS COMPANY 发明人 RAJOPADHYE MILAND;EDWARDS DAVID SCOTT;HARRIS THOMAS DAVID;HEMINWAY STUART J.;LIU SHUANG;SINGH PRAHLAD R.
分类号 A61K45/00;A61K49/00;A61K49/04;A61K51/00;A61K51/08;A61M36/14;A61P29/00;A61P35/00;C07D401/12;C07D401/14;C07K7/00;(IPC1-7):C07K7/64;C07K7/56 主分类号 A61K45/00
代理机构 代理人
主权项
地址